Progesterone - Amilar Pharmaceuticals

Drug Profile

Progesterone - Amilar Pharmaceuticals

Alternative Names: BIO-036

Latest Information Update: 23 Jan 2015

Price : $50

At a glance

  • Originator Amilar Pharmaceuticals
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Infertility; Menopausal syndrome; Pregnancy

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 23 Jan 2015 Discontinued - Phase-I for Menopausal syndrome in USA (unspecified route)
  • 23 Jan 2015 Discontinued - Preclinical for Contraception in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top